Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People who took Viread were about two thirds less likely to develop HCC, but this could be related to other factors as well.
Keytruda and Opdivo showed antitumor activity in some patients and acceptable side effects in real-world use.
Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.
The VA has cured HCV in nearly 100,000 veterans, which will dramatically reduce the development of advanced liver disease and liver cancer.
Being diagnosed with liver cancer at a later stage of the disease was associated with a lower three-year survival rate.
A European study of nearly 19,000 people with HIV also found that curing hep C was not associated with heart disease or non-AIDS cancer.
Hepatitis C can lead to a variety of complications such as cirrhosis, portal hypertension, liver cancer, and liver transplant.
Hepatitis C patients have a higher risk factor for liver cancer and other associated liver conditions.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
A look at two recent cancer studies. One showing an increased hepatitis prevalence in cancer patients; the other looks at high fiber diets.
A study found that people who had the largest increase in whole grain lowered their liver cancer risk by nearly 40 percent.
Highlights some of the latest hepatitis C and liver disease research.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.